• Users Online: 758
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 

    Article Cited by others


CD200 is an independent prognostic factor in multiple myeloma

Osman Amany A, Eissa Doaa G, Moussa Mohamed M

Year : 2014| Volume: 39| Issue : 3 | Page no: 177-181

   This article has been cited by
1 Phase I study of samalizumab in chronic lymphocytic leukemia and multiple myeloma: blockade of the immune checkpoint CD200
Daruka Mahadevan,Mark C. Lanasa,Charles Farber,Manjari Pandey,Maria Whelden,Susan J. Faas,Terrie Ulery,Anjli Kukreja,Lan Li,Camille L. Bedrosian,Xiaoping Zhang,Leonard T. Heffner
Journal for ImmunoTherapy of Cancer. 2019; 7(1)
[Pubmed]  [Google Scholar] [DOI]


Read this article